Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495144 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
A Phase 1 study of Hypoxia and Tumors, sponsored by Threshold Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 129
- Enrollment target
- 7
- Study locations
NCT00495144 is a Phase 1 study of Hypoxia and Tumors that has completed, run by Threshold Pharmaceuticals. The registered enrollment target is 129 participants, below the 3,114-participant average among 39 other Hypoxia trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT00495144, a Phase 1 study of Hypoxia and Tumors, has completed, sponsored by Threshold Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 129 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a phase I, multi-center, open-label, dose-escalation study of TH-302 in patients with advanced solid tumors. TH-302 is a hypoxia activated product designed to exploit the hypoxic nature of tumors. The study is designed to establish the safety including the maximum tolerated dose, the pharmacokinetics, and the anti-tumor activity of TH-302.
Interventions
- DRUG TH-302
Study Locations (7)
Arizona
- TGen Drug Development Services - Scottsdale
- Mayo Clinic Arizona - Scottsdale
California
- St. Mary's Medical Center - San Francisco
Indiana
- Indiana University Simon Cancer Center - Indianapolis
Minnesota
- Mayo Clinic Rochester - Rochester
Tennessee
- Sarah Cannon Research Institute - Nashville
Texas
- Mary Crowley Cancer Research Centers - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495144
The ClinicalTrials.gov registry entry for NCT00495144 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,114-participant average among 39 other Hypoxia trials with a reported enrollment target (96% lower). The listed sponsor is Threshold Pharmaceuticals, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which TH-302 is the first listed.
NCT00495144 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Arizona, California, Indiana.
Frequently Asked Questions
What is clinical trial NCT00495144 about?
NCT00495144 is a clinical study titled "A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors". This is a phase I, multi-center, open-label, dose-escalation study of TH-302 in patients with advanced solid tumors. TH-302 is a hypoxia activated product designed to exploit the hypoxic nature of tumors. The study is designed to establish the safety including the maximum tolerated dose, the pharmac...
What is the current status of trial NCT00495144?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 129 participants. The study started on 2007-06. Estimated completion is 2012-06.
What conditions does trial NCT00495144 study?
This clinical trial studies the following conditions: Hypoxia, Tumors.
What interventions are being tested in trial NCT00495144?
The interventions under investigation include: TH-302 (DRUG).
Who is sponsoring clinical trial NCT00495144?
This trial is sponsored by Threshold Pharmaceuticals, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00495144 being conducted?
This trial has 7 study locations across Arizona, California, Indiana, Minnesota, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
RECRUITING
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.